000211656 001__ 211656
000211656 005__ 20180317092329.0
000211656 013__ $$aUS2006105974$$bUS$$cA1$$d20060518
000211656 013__ $$aAU2003250145$$bAU$$cA1$$d20040123
000211656 013__ $$aWO2004004769$$bWO$$cA1$$d20040115
000211656 02470 $$2TTO$$a6.0284
000211656 02470 $$2EPO Family ID$$a9939866
000211656 037__ $$aPATENT
000211656 245__ $$aConjugates of photosensitizers and oligonucleotides for selective photochemiotherapy
000211656 260__ $$c2004
000211656 269__ $$a2004
000211656 336__ $$aPatents
000211656 520__ $$aThis invention relates to oligonucleotide targeting agents and their use in the treatment of diseased cells by selective photochemotherapy (PCT). PCT is a method of treating human diseases and disorders, bacteriological indications and other pathological conditions. PCT is based on the topical or systemic application of a photosensitizing agent, a precursor or pro-drug thereof, which preferentially accumulates in the target tissue. Irradiation of the photosensitizing agent located in the target. tissue with electromagnetic radiation of an appropriate wavelength and the interaction of the thus excited photosensitive moiety with oxygen leads to tissue damage and destruction of the irradiated areas.
000211656 700__ $$aVan, Den
000211656 700__ $$aLange, Norbert
000211656 909C0 $$0252376$$pLPAS
000211656 909C0 $$0252085$$pTTO$$xU10021
000211656 937__ $$aEPFL-PATENT-211656
000211656 973__ $$aEPFL
000211656 980__ $$aPATENT